SCHEMBL5167536

SCHEMBL5167536

CC(C)CC(C(=O)O)c1cccc(-c2ccc(C(F)(F)F)cc2)c1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 3/20 0.57
PSEN2 P49810 3/20 0.57
APH1B Q8WW43 3/20 0.57
NCSTN Q92542 3/20 0.57
APH1A Q96BI3 3/20 0.57
PSENEN Q9NZ42 3/20 0.57
APP P05067 2/20 0.46
AKR1C3 P42330 7/20 0.45
AKR1C2 P52895 7/20 0.45
TP53 P04637 1/20 0.39
BACE1 P56817 1/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
MMP2 P08253 2/20 0.38
MMP9 P14780 2/20 0.38
CYP2C8 P10632 1/20 0.38
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5204881 0.88 AKR1C3 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5168875 0.85 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5170727 0.84 MMP2 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5170546 0.83 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5168403 0.83 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5168620 0.81 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL27835587 0.79 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4597117 0.76 PSEN1 (0.72) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6472107 0.75 PSEN1 (0.79) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4597350 0.73 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773315-A1 ARYLACETIC ACIDS AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE Merck Sharp & Dohme Limited (GB) 2007-04-18 EP disclosed
WO-2006008558-A1 ARYLACETIC ACIDS AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER’S DISEASE MERCK SHARP & DOHME LIMITED (GB) 2006-01-26 WO disclosed